Details for New Drug Application (NDA): 018896
✉ Email this page to a colleague
NDA 018896 describes POTASSIUM ACETATE, which is a drug marketed by Exela Pharma, Fresenius Kabi Usa, and Hospira, and is included in four NDAs. It is available from three suppliers. Additional details are available on the POTASSIUM ACETATE profile page.
The generic ingredient in POTASSIUM ACETATE is potassium acetate. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium acetate profile page.
The generic ingredient in POTASSIUM ACETATE is potassium acetate. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium acetate profile page.
Summary for 018896
| Tradename: | POTASSIUM ACETATE |
| Applicant: | Hospira |
| Ingredient: | potassium acetate |
| Patents: | 0 |
Pharmacology for NDA: 018896
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 018896
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| POTASSIUM ACETATE | potassium acetate | INJECTABLE;INJECTION | 018896 | NDA | Hospira, Inc. | 0409-3294 | 0409-3294-25 | 25 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (0409-3294-25) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE (0409-3294-15) |
| POTASSIUM ACETATE | potassium acetate | INJECTABLE;INJECTION | 018896 | NDA | Hospira, Inc. | 0409-3294 | 0409-3294-51 | 25 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (0409-3294-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE (0409-3294-61) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2MEQ/ML | ||||
| Approval Date: | Jul 20, 1984 | TE: | AP | RLD: | Yes | ||||
Complete Access Available with Subscription
